WASHINGTON — It took nearly three weeks for a maker of eye drops to recall its products after the Food and Drug Administration requested a recall. There have been no reports of injuries, but some key lawmakers are arguing the time it took the FDA to coax a voluntary recall shows the agency should be given the power to force them.
Eye drops must be sterile because drugs applied to eyes bypass some of the body’s natural defenses.
FDA inspectors found unsanitary conditions at a facility in India that makes over-the-counter eye drop products that multiple U.S. retailers and distributors sell under their own brand names. Those brand names include CVS Health, Rite Aid, Target’s Up & Up.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect